Teladoc Health (TDOC) Cash from Investing Activities (2014 - 2026)

Teladoc Health has disclosed Cash from Investing Activities across 13 years of filings, most recently posting -$41.6 million for Q2 2026.

• In Q2 2026, Cash from Investing Activities rose 30.33% year-over-year to -$41.6 million; the TTM figure through Jun 2026 stood at -$161.2 million (up 33.89% YoY), while the FY2025 annual figure was -$266.0 million, down 114.43% from the prior year.
• Cash from Investing Activities came in at -$41.6 million for Q2 2026 at Teladoc Health, down from -$36.5 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of -$27.6 million in Q1 2022 to a low of -$123.3 million in Q1 2025.
• Average Cash from Investing Activities over 5 years is -$44.0 million, with a median of -$37.1 million recorded in 2023.
• Year-over-year, Cash from Investing Activities slumped 1968.13% in 2022 and soared 70.37% in 2026.
• Over 5 years, Cash from Investing Activities stood at -$53.9 million in 2022, then surged by 32.26% to -$36.5 million in 2023, then gained by 18.8% to -$29.6 million in 2024, then retreated by 15.77% to -$34.3 million in 2025, then fell by 21.19% to -$41.6 million in 2026.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were -$41.6 million in Q2 2026, -$36.5 million in Q1 2026, and -$34.3 million in Q4 2025.